Resolve Therapeutics

Resolve Therapeutics Resolve Therapeutics is pioneering first-in-class compounds for primary Sjögren’s disease.

Our lead product candidate, RSLV-132, has the potential to prevent the inflammation that causes the debilitating symptoms of autoimmune diseases.

Patient Story: Staci W. – Hurricane, UTDiagnosed with Sjögren’s in 2022, Staci shares how the journey to treatment was l...
06/20/2025

Patient Story: Staci W. – Hurricane, UT
Diagnosed with Sjögren’s in 2022, Staci shares how the journey to treatment was long and challenging, but ultimately hopeful. Today, her symptoms include vaginal dryness and dry eyes. Through it all, she reminds us:

🗣 “You don’t have to look far to find a miracle. A seed blossoming into a flower, an acorn into a mighty oak tree, or a single cell into a human being.”

📍Location: Hurricane, UT
🕊️ Sjögren’s and lupus taught her to slow down and appreciate life’s little joys.
📸 Photo shared with permission.

Coming up tomorrow: a real story from a Sjögren’s patient navigating symptoms, setbacks, and strength. 💬 Stay tuned for ...
06/19/2025

Coming up tomorrow: a real story from a Sjögren’s patient navigating symptoms, setbacks, and strength. 💬 Stay tuned for a powerful perspective in our Voices of Sjögren’s series.

̈grensawareness

Staying hydrated can make a difference, especially when dryness is a daily challenge for those living with Sjögren’s dis...
06/18/2025

Staying hydrated can make a difference, especially when dryness is a daily challenge for those living with Sjögren’s disease. Simple changes can go a long way.

🔗 Learn more about our current clinical trial:
https://resolvetherapeutics.com/clinical-trial

⚠️ This is not medical advice. Always consult your healthcare provider before making changes to your routine.

At Resolve, we share patient voices to remind everyone with Sjögren’s that they’re part of a strong, resilient community...
06/17/2025

At Resolve, we share patient voices to remind everyone with Sjögren’s that they’re part of a strong, resilient community.

💬 Want to share your story? Email us at [email protected]

̈grensawareness

Research HighlightResearch is bringing hope to those living with Sjögren’s.Resolve is conducting a Phase 2 clinical tria...
06/15/2025

Research Highlight

Research is bringing hope to those living with Sjögren’s.
Resolve is conducting a Phase 2 clinical trial evaluating RSLV-132, an investigational treatment that may help address fatigue and dryness.

📄 Learn more on clinicaltrials.gov/study/NCT06440525
📌 Or visit: resolvetherapeutics.com/clinical-trial

̈grensawareness

Myth vs FactAt Resolve, we’re committed to advancing research that targets these widespread, systemic symptoms.🔗 Learn m...
06/15/2025

Myth vs Fact

At Resolve, we’re committed to advancing research that targets these widespread, systemic symptoms.

🔗 Learn more: resolvetherapeutics.com/clinical-trial
̈grensawareness

Self-Care TipKeeping your lips and mouth moist can make a big difference in daily comfort.Some people living with Sjögre...
06/13/2025

Self-Care Tip
Keeping your lips and mouth moist can make a big difference in daily comfort.
Some people living with Sjögren’s find relief by using sugar-free lozenges or running a humidifier, especially during sleep or in dry climates.

This tip is for general wellness. Always talk to your doctor for medical advice.

Learn more about our ongoing work in Sjögren’s research:
🔗 resolvetherapeutics.com/clinical-trial

Quote of the DaySjögren’s disease affects millions, and fatigue is often the most difficult symptom to explain, yet it’s...
06/12/2025

Quote of the Day

Sjögren’s disease affects millions, and fatigue is often the most difficult symptom to explain, yet it’s also one of the most common.
At Resolve Therapeutics, we’re working to address this often-overlooked burden through ongoing research and clinical trials.

Learn more about our efforts to develop new approaches for Sjögren’s:
🔗 resolvetherapeutics.com/clinical-trial

̈grensawareness

🌎 Now Enrolling Across 23 U.S. Locations!A new clinical trial is underway for women diagnosed with Sjögren’s disease who...
06/12/2025

🌎 Now Enrolling Across 23 U.S. Locations!
A new clinical trial is underway for women diagnosed with Sjögren’s disease who are experiencing moderate-to-severe symptoms of fatigue and dryness. The research is currently being conducted at 23 clinical sites across the United States, including major cities in Florida, Texas, California, Pennsylvania, Massachusetts, North Carolina, New Mexico, Utah, Washington, and Illinois.

If you’re interested in participating or learning more, visit resolvetherapeutics.com/clinical-trial or check the official listing at clinicaltrials.gov/study/NCT06440525.

🧪 Your story matters. Your participation could help shape the future of Sjögren’s care.

05/10/2025

Sjögren’s affects millions worldwide with no approved treatment. Resolve Therapeutics is committed to developing a new approach. Learn more about our mission at resolvetherapeutics.com. If you’d like your voice to be heard or are living with Sjögren’s and want to share your story, email us at [email protected]. Watch the extended episode on YouTube: https://youtu.be/xFA-V-sGj6k.

Watch the third episode of The Voices of Sjögren’s featuring Mary Dacey! The extended episode is now available on YouTub...
05/10/2025

Watch the third episode of The Voices of Sjögren’s featuring Mary Dacey! The extended episode is now available on YouTube. Check it out here: https://youtu.be/xFA-V-sGj6k.

03/13/2025

Sjögren’s affects millions worldwide with no approved treatment. Resolve Therapeutics is committed to developing a new approach. Learn more about our mission at resolvetherapeutics.com. If you’d like your voice to be heard or are living with Sjögren’s and want to share your story, email us at [email protected]. Watch the extended episode on YouTube: https://youtu.be/pwEGSz8aoG4.

Address

1951 NW 7th Avenue, Suite 300
Miami, FL
33136

Alerts

Be the first to know and let us send you an email when Resolve Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share